 TEL AVIV, Israel and BETHESDA, Md., Sept. 13, 2021 PRNewswire -- Cannabics Pharmaceuticals Inc. OTCQB: CNBX, a global leader in the development of cancer related cannabinoid-based medicine and a pioneer in the development of psychedelic inspired medicine, announced today that Dr. Ilya Reznik MD, a renowned Neuropsychiatrist, has joined the company as Head of Psychedelic Inspired Medicine. 